Skip to main content
. 2022 Jun 6;37(4):593–602. doi: 10.46497/ArchRheumatol.2022.9117

Table 4. Univariate and multivariate logistic regression analyses for factors associated with the presence of IR in RA patients.

  Univariate Multivariate
OR 95% CI p OR 95% CI p
Age (year) 1.1 1.013-1.193 0.023 1.096 1.011-1.187 0.026
Sex 0.577 0.137-2.431 0.453 1.617 0.389-6.73 0.509
Menopausal status 0.552 0.013-23.739 0.757      
Body mass index 1.286 0.98-1.688 0.07 1.258 0.969-1.633 0.085
Disease duration (weeks) 1.07 0.765-1.497 0.693      
DAS28 score 6.003 1.638-22.005 0.007 5.75 1.754-18.844 0.004
RF (IU/mL) 1.001 0.999-1.002 0.505      
Anti-CCP (RU/mL) 0.999 0.998-1.001 0.396 0.999 0.998-1.001 0.475
C-reactive protein 1.047 1.018-1.076 0.001 1.047 1.018-1.076 0.001
Erythrocyte sedimentation rate 0.983 0.954-1.013 0.265 0.981 0.953-1.011 0.213
Using NSAIDs 1.911 0.219-16.651 0.558      
IR: Insulin resistance; RA: Rheumatoid arthritis; CI: Confidence interval; DAS28: 28-joint disease activity score; RF: Rheumatoid factor; Anti-CCP: Anti-cyclic citrullinated peptide; NSAIDs, nonsteroidal anti-inflammatory drugs; Menopausal status is for female group. A p value <0.05 is considered as statistically significant.